Connection
Ashley Brooks-Russell to Cannabinoid Receptor Agonists
This is a "connection" page, showing publications Ashley Brooks-Russell has written about Cannabinoid Receptor Agonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.310 |
|
|
|
-
Kosnett MJ, Ma M, Dooley G, Wang GS, Friedman K, Brown T, Henthorn TK, Brooks-Russell A. Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):355-362.
Score: 0.213
-
Rague JM, Ma M, Dooley G, Wang GS, Friedman K, Henthorn TK, Brooks-Russell A, Kosnett MJ. The minor cannabinoid cannabigerol (CBG) is a highly specific blood biomarker of recent cannabis smoking. Clin Toxicol (Phila). 2023 05; 61(5):363-369.
Score: 0.053
-
Karoly HC, Milburn MA, Brooks-Russell A, Brown M, Streufert J, Bryan AD, Lovrich NP, DeJong W, Cinnamon Bidwell L. Effects of High-Potency Cannabis on Psychomotor Performance in Frequent Cannabis Users. Cannabis Cannabinoid Res. 2022 02; 7(1):107-115.
Score: 0.044